Ongoing PrEP Trials
Ongoing
& Planned Trials of Intermittent PrEP
(i-PrEP) - (November 2009)
This PrEP Research Subcommittee piece provides an update on the ongoing and planned i-PrEP trials being conducted by IAVI and HPTN.
PrEP Trials Table - (PDF) (JPG) - March 2010
Table contains information about ongoing trials of oral PrEP and topical microbicides.
PrEP Trials Map - (PDF) (JPG) - December 2009
PrEP-specific map gives a view of ongoig and completed PrEP trials worldwide.
PrEP Trials Timeline - (PDF) (JPG) - March 2010
Timeline charts past PrEP trials and provides estimated end-dates for ongoing trials.
FEM-PrEP Trial Newsletter - (Issue 2 - July 09), (Issue 1 - January 09)
Newsletter provides trial information, updates and community perspectives on the FEM-PrEP trial, which is ongoing in Kenya, Malawi, South Africa, Tanzania, and Zambia and is designed to test the safety and effectiveness of Truvada for HIV prevention.
iPrEx Trial Update - (Q1 2009), (Q2 2009), (Q3 2010), (Q4 2010)
Update provides trial information, updates and community perspectives on the iPrEx trial, which is ongoing in Brazil, Ecuador, Peru, South Africa, Thailand and the US and is designed to test the safety and efficacy of daily oral tenofovir and emtricitabine (Truvada) for HIV prevention. Visit the iPrEX webpage to find these resources in other languages.
This PrEP Research Subcommittee piece provides an update on the ongoing and planned i-PrEP trials being conducted by IAVI and HPTN.
PrEP Trials Table - (PDF) (JPG) - March 2010
Table contains information about ongoing trials of oral PrEP and topical microbicides.
PrEP Trials Map - (PDF) (JPG) - December 2009
PrEP-specific map gives a view of ongoig and completed PrEP trials worldwide.
PrEP Trials Timeline - (PDF) (JPG) - March 2010
Timeline charts past PrEP trials and provides estimated end-dates for ongoing trials.
FEM-PrEP Trial Newsletter - (Issue 2 - July 09), (Issue 1 - January 09)
Newsletter provides trial information, updates and community perspectives on the FEM-PrEP trial, which is ongoing in Kenya, Malawi, South Africa, Tanzania, and Zambia and is designed to test the safety and effectiveness of Truvada for HIV prevention.
iPrEx Trial Update - (Q1 2009), (Q2 2009), (Q3 2010), (Q4 2010)
Update provides trial information, updates and community perspectives on the iPrEx trial, which is ongoing in Brazil, Ecuador, Peru, South Africa, Thailand and the US and is designed to test the safety and efficacy of daily oral tenofovir and emtricitabine (Truvada) for HIV prevention. Visit the iPrEX webpage to find these resources in other languages.